US and EU practice styles similar

Article

The practice styles and choices of US and EU ophthalmologists are very similar with the greatest differences apparent in refractive surgery, David Leaming said.

The practice styles and choices of US and EU ophthalmologists are very similar with the greatest differences apparent in refractive surgery, David Leaming said. Dr Leaming revealed the results of the ESCRS/ASCRS comparison survey, which tracks practice choices in both societies.

A multiple-choice survey was mailed to all US ASCRS members not in training and all ESCRS EU members to ascertain their practice styles. The questions were for the most part identical so that valid comparisons could be obtained. In Europe, 656 questionnaires were returned from 3,070 sent out, or a 21% response rate, while there was just a 14% response rate, or 628 questionnaires, in the US.

Intraocular surgical techniques were similar for both societies with EU country differences highlighted. The biggest difference was found in the refractive area. Alcon's Infiniti is the most popular phaco machine in the US (33%), but only one-third in Europe (16%), behind the Alcon Legacy (24%) and Bausch & Lomb's Millennium.

While VISX (66%) dominates the US market in laser machines, there is a much greater variation in laser machine use in Europe, though Bausch & Lomb's Technolas leads (28%) followed by Wavelight (20%). Also there is a greater use of phakic IOLs in Europe (24%) as compared to the US (9%).

There are many more results available on the study author's website, http://www.leamingsurveys.com/

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.